The New Combination Docetaxel, Prednisone and Curcumin in Patients with Castration-Resistant Prostate Cancer: A Pilot Phase II Study

Oncology
Hakim MahammediJean-Christophe Eymard

Abstract

Favorable phase I results justified this pilot phase II study to assess the efficacy of docetaxel/curcumin in patients with chemotherapy-naive metastatic castration-resistant prostate cancer (CRPC). Thirty patients with progressing CRPC and a rising prostate-specific antigen (PSA) received docetaxel/prednisone in standard conditions for 6 cycles in combination with per os curcumin, 6,000 mg/day (day -4 to day +2 of docetaxel). The co-primary endpoint was the overall response rate determined by PSA and target assessments. An ancillary study assessed the seric values of chromogranin A (CgA) and neuron-specific enolase (NSE). Twenty-six patients received the scheduled treatment, 2 progressed and 2 died before the end of treatment. A PSA response was observed in 59% of patients (14% of PSA normalization) and achieved within the first three cycles for 88% of responders. Partial response was reached for 40% of evaluable patients. The regimen was well tolerated, and no adverse event was attributed to curcumin. Twenty patients were 100% curcumin compliant. The PSA level and objective response rate were not correlated with the serum values of CgA and NSE. This study produced additional data on curcumin as a treatment for cancer, with a ...Continue Reading

Citations

Sep 22, 2016·Clinical Epigenetics·Inês GraçaCarmen Jerónimo
Nov 23, 2016·Nature Reviews. Urology·Veronica Rodriguez-BravoJosep Domingo-Domenech
Sep 9, 2017·The International Journal of Biological Markers·Barbara MuoioEnrico Roggero
Mar 23, 2018·The Tohoku Journal of Experimental Medicine·Jo-Woong ChoiMin-Sun Kim
Sep 1, 2017·Acta Pharmaceutica : a Quarterly Journal of Croatian Pharmaceutical Society and Slovenian Pharmaceutical Society, Dealing with All Branches of Pharmacy and Allied Sciences·Fengling WangWeidong Chen
May 17, 2018·Nutrition and Cancer·Annapoorna SreedharYunfeng Zhao
Feb 23, 2018·Phytotherapy Research : PTR·Maria MantzorouConstantinos Giaginis
Feb 24, 2019·Critical Reviews in Food Science and Nutrition·Pan PanLi-Shu Wang
Jan 16, 2020·International Journal of Molecular Sciences·Teodora CosteaMaria-Magdalena Mocanu
May 30, 2020·International Journal of Molecular Sciences·Jochen RutzBorna Relja
Aug 14, 2020·Nanomaterials·Sibusiso Alven, Blessing Atim Aderibigbe
Jun 10, 2016·International Journal of Cancer. Journal International Du Cancer·Hamed MirzaeiAmirhossein Sahebkar
Aug 17, 2017·Nutrition in Clinical Practice : Official Publication of the American Society for Parenteral and Enteral Nutrition·Mary J Marian
Dec 13, 2017·Archives of Pharmacal Research·Yumeng WeiLing Zhao
Apr 16, 2019·Evidence-based Complementary and Alternative Medicine : ECAM·Frederik RoosRoman A Blaheta
May 11, 2018·Oxidative Medicine and Cellular Longevity·Marzena WojcikLucyna Alicja Wozniak
Jan 12, 2019·Critical Reviews in Food Science and Nutrition·Sita Sharan PatelPriyal Jain
Mar 3, 2020·Frontiers in Pharmacology·Amit S ChoudhariOm Prakash
Jul 2, 2020·Seminars in Cancer Biology·Elina KhatoonAjaikumar B Kunnumakkara
May 5, 2020·Current Drug Targets·Fatemeh Forouzanfar, Seyed Hadi Mousavi
Jan 16, 2021·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Baohua WangLei Wang
Jan 20, 2020·Acta Pharmaceutica : a Quarterly Journal of Croatian Pharmaceutical Society and Slovenian Pharmaceutical Society, Dealing with All Branches of Pharmacy and Allied Sciences·Fengling WangWeidong Chen
Sep 24, 2016·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Hojjat AhmadzadehfarMarkus Essler
May 21, 2021·Colloids and Surfaces. B, Biointerfaces·Anuja S KulkarniVaishali S Shinde
Jul 25, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Wei-Yang KongLay-Hong Chuah
Aug 8, 2021·International Journal of Molecular Sciences·Paulina WignerJoanna Saluk-Bijak

❮ Previous
Next ❯

Related Concepts

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.